Pituitary adenylate cyclase-activating polypeptide (PACAP) and the closely related neuropeptide vasoactive intestinal peptide (VIP), exhibit widespread expression in the central and peripheral nervous ...
Molecular imaging could have great utility for detecting, classifying, and guiding treatment of brain disorders, but existing probes offer limited capability for assessing relevant physiological ...
EA activates sympathetic BM terminals to release pituitary adenylate cyclase activating polypeptide (PACAP). PACAP-receptor PAC1-antagonists abrogate the effects of EA, whereas PAC1-agonists mimic EA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback